Abraxis BioScience, Inc., an integrated biotechnology company, today announced that the European Commission has granted marketing approval for ABRAXANE powder for suspension for infusion (an albumin-bound nanoparticle formulation of paclitaxel) for the treatment of metastatic breast cancer in patients who have failed first-line treatment for metastatic disease and for whom standard, anthracycline-containing therapy is not indicated.
Jan 23rd, 2008
Read more
Applied DNA Sciences, Inc. announced that it has filed multiple patent applications to cover its latest developments in optical reporter markers. These reporters 'announce' the presence of the DNA markers to which they are attached.
Jan 23rd, 2008
Read more
Nanostellar CEO Pankaj Dhingra will join a list of distinguished panelists at the World Economic Form in Davos, Switzerland, to address the entrepreneurial opportunities created by global warming. The panel, which takes place January 24, 2008, will turn its attention to the opportunities that the development and growth of 'green' initiatives can play in job creation and economic stimulation.
Jan 22nd, 2008
Read more
Molecular Profiles, a global leader in the provision of innovative contract research services to the pharmaceutical, biopharmaceutical and biomedical sectors, announces the latest addition to its comprehensive nanoscale analytical services offering, nanoPASSTM (nanoscale Predictive Analytical Screening Solution).
Jan 22nd, 2008
Read more
NanoViricides, Inc. reported today that they are on course with the development of nanoviricides drug candidates against highly pathogenic avian influenzas (HPAI) including H5N1 bird flu, and common influenza.
Jan 22nd, 2008
Read more
NanoInk, Inc. announced today the appointment of James M. Hussey, 48, as its Chief Executive Officer, as well as a member of its Board of Directors.
Jan 22nd, 2008
Read more
Arrowhead Research Corporation announced today that its President & CEO, Dr. Christopher Anzalone, will present at the 7th Annual Rice Alliance Nanotechnology Forum on January 24, 2008 at 4:00 pm CT in Houston, Texas.
Jan 22nd, 2008
Read more
Octillion Corp., an alternative energy technology incubator, today announced the appointment of nanotechnology and engineering expert, Prof. T.C. Yih, to the Company's Advisory Board.
Jan 22nd, 2008
Read more
A new white paper examines Neutron Activation Analysis (NAA) as a means for testing contaminant levels for healthcare solutions based on nanotechnology. The white paper, posted on ElementalAnalysis.com, discusses how NAA tests exhibit accuracies up to parts per quadrillion.
Jan 22nd, 2008
Read more
According to a new technical market research report from BCC Research, the Chinese market for advanced materials was worth $30.5 billion in 2007. This is expected to increase to over $60.5 billion by 2012, a compound average annual growth rate (CAGR) of 14.7%.
Jan 21st, 2008
Read more
BioAlliance Pharma SA has announced its financial calendar for 2008, which notably includes the publication dates for its revenue statements and half-year and annual accounts, as well as the date of its shareholders' Annual General Meeting:
Jan 21st, 2008
Read more
NanoTechnologies (U.K.), a Sedgefield-based developer and manufacturer of nanotechnology air-monitoring equipment, such as 'sniffer machines' for detecting airborne contaminates including biochemicals, biological agents and explosives, said Monday that it has appointed W H Ireland Corporate Finance as broker.
Jan 21st, 2008
Read more
Company's Solar Silicon 4.0 technology will debut at IBF Nanotechnology Investment Forum 02/06/08.
Jan 21st, 2008
Read more
Dolomite has announced that its microfluidic device fabrication expertise is being used by automated laboratory equipment specialist, Syrris Ltd, within its novel range of flow reactor instruments. These microfluidic flow reactor modules supplied by Dolomite, enable the fast and efficient processing of chemicals for test and analysis.
Jan 19th, 2008
Read more
Nanotechnology developer Arrowhead Research Corp. said Friday its subsidiary Calando Pharmaceuticals Inc. will become part of another of its subsidiaries, Insert Therapeutics Inc.
Jan 19th, 2008
Read more
CODIXX extends the colorPol polarizer product family with the colorPol MIR to cover the mid infrared range.
Jan 18th, 2008
Read more
Subscribe to our Nanotechnology Business News feed